过去一年中添加的文章,按日期排序

… (CONCORDE) phase Ib platform study of novel DNA damage response inhibitor (DDRi) agents in combination with radiotherapy in non-small cell lung cancer  …

A Greystoke, JB Oughton, SR Brown, K Butterworth… - 2024 - ascopubs.org
39 天前 - … Background: Lung cancer is the leading cause of cancer mortality globally, with cases
… assess multiple DDRi in combination with radical thoracic RT (60Gy in 30 fractions over 6 …

… II trial of atezolizumab with or without tiragolumab before and after definitive chemoradiation for unresectable stage III non-small cell lung cancer (NSCLC; AFT-57).

HJ Ross, DE Kozono, MD Mix, JJ Urbanic, TM Williams… - 2024 - ascopubs.org
39 天前 - TPS8123 Background: A minority of patients with unresectable stage III non-small
cell lung cancer (NSCLC) may be cured by chemoradiotherapy (CRT). Adjuvant checkpoint …

JCOG2002: A randomized phase III study of thoracic radiotherapy for extensive stage small cell lung cancer.

K Nosaki, Y Zenke, S Nomura, T Sasaki, S Niho, K Yoh… - 2024 - ascopubs.org
39 天前 - TPS8132 Background: Consolidative thoracic radiotherapy (cTRT) has shown a
marginal improvement in overall survival (OS) and progression-free survival (PFS) for extensive…

… 1 trial: Pemetrexed-cisplatin plus bevacizumab or concurrent thoracic radiation therapy followed by surgery in stage IIIA (N2) nonsquamous non-small cell lung cancer …

K Takamochi, K Suzuki, M Tsuboi, S Niho, S Ishikura… - 2024 - ascopubs.org
39 天前 - … (BEV arm) or concurrent thoracic radiation therapy (TRT arm) followed by surgery
in patients with stage IIIA (N2) nonsquamous non-small cell lung cancer (NSCLC). The TRT …

Cost analysis of targeted and immunotherapies in operable esophageal and non-small cell lung cancers.

Y Alwatari, M Shanshal, NC Johnson, V Thao… - 2024 - ascopubs.org
39 天前 - … -small cell lung cancers (NSCLC) and esophageal cancers (… and qualify for adjuvant
therapy (Stage IB – IIA with high-… of eligible operable thoracic malignancies could exceed …

Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series.

YK Chae, T Demir, LILY Chung, W Woo, C Moloney… - 2024 - ascopubs.org
39 天前 - … in lung transplantation, lung cancer constituted less than 0.1% of the lung transplantation
… Results: Six patients with stage IVA NSCLC who underwent lung transplantation were …

… chemoradiotherapy and camrelizumab consolidation therapy versus standard chemoradiotherapy as first-line treatment for limited-disease small cell lung cancer.

X Yaping, J Ni, S Ren, X Xu, M Hu, Q Xu, Y Chen… - 2024 - ascopubs.org
39 天前 - … significant clinical benefits in extensive-stage small cell lung cancer (SCLC). However,
for … For thoracic radiation, 45 Gy in 3 weeks (1.5 Gy, BID) was given on the first day of the …

Lung cancer MDT quality assessment: A nationwide study.

J Berg, C Aamelfot, SG Aanes, M Wilskow… - 2024 - ascopubs.org
39 天前 - … , patients with lung cancer are discussed at local MDT (without a thoracic surgeon
… For 10 of the 12 there were differences in stage assessment, from stage IIIA-BC to IV, and in …

CASTOR1 phosphorylation as a predictor of survival in male patients with KRAS-mutated lung adenocarcinoma.

SK Loo, G Sica, X Wang, T Li, L Chen, A Gaither-Davis… - 2024 - ascopubs.org
39 天前 - … Background: Lung cancer, a leading global cause of cancer-related mortality, …
independent cohorts of patients who underwent thoracic surgical procedures at the University of …

Overall survival of adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line treatment for extensive-stage small cell lung cancer.

D Chen, A Gao, B Zou, W Huang, Q Shao, X Meng… - 2024 - ascopubs.org
39 天前 - … (pts) with extensive-stage small cell lung cancer (ES-SCLC). … chemotherapy and
sequential thoracic radiotherapy (TRT) … Pts then entered the maintenance treatment stage with …